Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Debt / NOTE 2.250% 5/1
-
Market price (% of par)
-
135.19%
-
Total 13F principal
-
$353,344,000
-
Principal change
-
+$29,609,000
-
Total reported market value
-
$477,872,921
-
Number of holders
-
49
-
Value change
-
+$37,386,038
-
Number of buys
-
20
-
Number of sells
-
19
Institutional Holders of NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 as of Q1 2021
As of 31 Mar 2021,
NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 was held by
49 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$353,344,000
in principal (par value) of the bond.
The largest 10 bondholders included
FRANKLIN RESOURCES INC, TENOR CAPITAL MANAGEMENT Co., L.P., Invesco Ltd., MACKAY SHIELDS LLC, WELLS FARGO & COMPANY/MN, UBS ASSET MANAGEMENT AMERICAS INC, LORD, ABBETT & CO. LLC, JANUS HENDERSON GROUP PLC, WOLVERINE ASSET MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC.
This page lists
49
institutional bondholders reporting positions
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.